what products does haleos labs make

Haleos Labs produces Active Pharmaceutical Ingredients (APIs), their intermediates, and a range of finished drug formulations including solid and liquid dosage forms.

what sector is haleos labs in

Haleos Labs operates in the pharmaceutical sector, specifically within the specialty and generic drug manufacturing industry.

when was haleos labs founded

Haleos Labs was founded in 1990 and is based in Hyderabad, India.

Haleos Labs is owned by its shareholders, with the company being a publicly listed entity on the National Stock Exchange of India (NSE) under the ticker HALEOSLABS.

HALEOS LABS LIMITED (HALEOSLABS) Share Price Today — ₹1,342.05

HALEOS LABS LIMITED (HALEOSLABS) live stock price is ₹1,342.05. Listed on BSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View HALEOS LABS LIMITED stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for HALEOS LABS LIMITED. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

HALEOSLABS

BSE

HALEOS LABS LIMITED

Healthcare· Pharmaceuticals & Biotechnology· INE320X01016· Scrip: 540679

EN हिन्दी ગુજરાતી मराठी

₹1,342.05

▲ 72.95 (+0.00%)

2026-06-10

BSE

₹1,342.05

▲ 72.95

+0.00%

121 trading days · 1Y period

TODAY (BSE)

Open1,341.10

High1,342.15

Low1,341.10

Prev Close1,415.00

Volume6

Value₹0.0Cr

L: 1,341.10H: 1,342.15

Info

Face Value₹10

Listed2017-08-17

ISININE320X01016

SeriesB

BSE Scrip540679

Key Metrics

1D

—

1W

—

1M

—

3M

—

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

Mkt Cap—

Growth (QoQ)

Revenue+7.82%

PAT+47.05%

EPS+16.95%

Profitability

EBITDA Margin17.6%

Net Margin5.7%

TTM EBITDA M.15.7%

TTM Net M.6.2%

Dividend

Yield—

Latest DPS₹1.5

Payout Ratio8.3%

Growth+0.00%

TTM Revenue

₹340 Cr

TTM EBITDA

₹53 Cr

TTM PAT

₹21 Cr

TTM EPS

₹74.44

Rev/Share

₹1123.4

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	85 Cr	78 Cr	15 Cr	7 Cr	5 Cr	₹18.08
2024-09-30	78 Cr	76 Cr	12 Cr	5 Cr	3 Cr	₹15.46
2024-06-30	87 Cr	77 Cr	12 Cr	10 Cr	6 Cr	₹21.37
2024-03-31	90 Cr	85 Cr	14 Cr	7 Cr	6 Cr	₹19.53
2023-12-31	72 Cr	69 Cr	10 Cr	4 Cr	4 Cr	₹14.24
2023-09-30	69 Cr	68 Cr	10 Cr	2 Cr	-0 Cr	₹2.20
2023-03-31	64 Cr	66 Cr	7 Cr	2 Cr	2 Cr	₹5.66
2022-12-31	88 Cr	83 Cr	12 Cr	6 Cr	4 Cr	₹13.18

Shareholding Pattern

CURRENT — 2026-03-31

Promoter72.1%

DII0.3%

Public27.9%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2025-09-24	Dividend	Dividend - Rs 1.50 Per Share
2024-09-23	Dividend	Annual General Meeting/Dividend - Rs 1.50 Per Share
2023-09-22	Dividend	Annual General Meeting/Dividend - Rs 1.50 Per Share
2022-09-22	Dividend	Annual General Meeting/Dividend - Rs 1.50 Per Share
2021-09-20	Dividend	Annual General Meeting/Dividend - Rs 1.50 Per Share
2019-09-19	Dividend	Dividend - Rs 1.50 Per Share
2018-09-12	Other	Annual General Meeting

Earnings Transcripts

SMS Lifesciences India Limited has informed the Exchange regarding 'Investor Presentation for the qu...

14 Jul 2025NSE9K chars

Read →

Price History

Date	Open	High	Low	Close	Volume
2026-06-10	1,372.70	1,405.80	1,369.20	1,400.50	562
2026-06-03	1,499.10	1,499.10	1,401.00	1,431.70	1,443
2026-05-27	1,667.00	1,667.00	1,616.70	1,631.50	1,054
2026-05-26	1,640.10	1,679.90	1,600.00	1,659.70	1,020
2026-05-25	1,759.90	1,759.90	1,640.10	1,664.00	768
2026-05-22	1,690.00	1,734.90	1,640.10	1,658.80	1,089
2026-05-21	1,639.90	1,699.00	1,577.60	1,686.20	2,789
2026-05-20	1,578.90	1,637.40	1,578.90	1,608.70	1,502
2026-05-19	1,530.00	1,569.40	1,519.00	1,556.50	410
2026-05-18	1,563.90	1,564.00	1,507.20	1,518.80	348
2026-05-15	1,602.00	1,619.40	1,555.80	1,564.70	1,012
2026-05-14	1,566.00	1,659.90	1,566.00	1,611.00	2,897
2026-05-13	1,730.00	1,730.00	1,561.00	1,563.00	2,350
2026-05-12	1,632.00	1,719.20	1,630.90	1,690.10	3,351
2026-05-11	1,700.00	1,774.00	1,555.00	1,599.80	7,491
2026-05-08	1,616.00	1,679.00	1,570.00	1,643.30	2,588
2026-05-07	1,608.00	1,627.20	1,560.10	1,616.00	2,703
2026-05-06	1,497.80	1,625.00	1,491.40	1,604.50	9,853
2026-05-05	1,518.90	1,518.90	1,460.10	1,483.80	1,191
2026-05-04	1,499.00	1,549.00	1,473.40	1,513.80	2,480
2026-04-30	1,508.30	1,544.50	1,440.00	1,456.80	1,733
2026-04-29	1,494.00	1,559.90	1,450.00	1,500.80	6,473
2026-04-28	1,350.00	1,489.00	1,350.00	1,438.70	2,516
2026-04-27	1,400.50	1,410.50	1,319.70	1,360.80	1,671
2026-04-24	1,411.00	1,448.30	1,374.70	1,387.90	682
2026-04-23	1,329.90	1,414.00	1,329.90	1,384.90	2,721
2026-04-22	1,309.30	1,348.40	1,309.30	1,330.30	2,731
2026-04-21	1,342.60	1,348.90	1,315.00	1,315.00	774
2026-04-20	1,297.90	1,345.00	1,281.50	1,327.80	4,325
2026-04-17	1,280.50	1,300.00	1,280.00	1,293.90	699

Frequently Asked Questions

About

HaleosLabs Limited, formerly known as SMS Lifesciences India Limited and established in 1990, is an Indian pharmaceutical company based in Hyderabad specializing in the manufacturing of active pharmaceutical ingredients (APIs) and intermediates. The company has expanded from a single-product facility to a multi-location organization with its own research center, serving both domestic and international markets. Notably, it rebranded to HaleosLabs Limited in August 2025.

BOARD OF DIRECTORS

Veeravenkata Satyanarayana Murthy Talluri

Managing Director

Sundaramma Patibandla

Independent Director

Venkafasubbarao Pollurl

Independent Director

DEPARTED

Jubilee Hills